A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea

首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea

【24h】

A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea

机译：患有原发性和继发性血症患者1毫克/天的多中心，随机，安慰剂控制，双盲，DIENOGEST的比较研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To evaluate the efficacy and safety of dienogest (DNG), a progestational 19-norsteroid, in patients with primary and secondary dysmenorrhea.

机译：目的：评价患有次生和继发性困难患者的DieNogest（DNG），孕激发性19-NORSTEROID的疗效和安全性。

著录项

来源
《Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society》 |2020年第3期|共10页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类妇科学;
关键词
Dienogest; double-blind; randomized study; dysmenorrhea; placebo-controlled study;

机译：Dienogest;双盲;随机研究;痛经;安慰剂对照研究;

相似文献

外文文献
中文文献
专利

1. A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea [J] . Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society . 2020,第3期

机译：患有原发性和继发性血症患者1毫克/天的多中心，随机，安慰剂控制，双盲，DIENOGEST的比较研究
2. A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of a far infrared-emitting sericite belt in patients with primary dysmenorrhea. [J] . Lee CH, Roh JW, Lim CY, Complementary therapies in medicine . 2011,第4期

机译：一项多中心，随机，双盲，安慰剂对照试验，评估远红外发射绢云母带在原发性痛经患者中的疗效和安全性。
3. Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study [J] . Osuga Yutaka, Fujimoto-Okabe Haruka, Hagino Atsushi Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society . 2017,第4期

机译：评估患有腺小学患者疼痛症状的疗效和安全性：随机，双盲，多中心，安慰剂对照研究
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Efficacy and safety of herbal medicine (Dangguijagyag-san) for primary dysmenorrhea: study protocol for a randomized double-blind placebo-controlled parallel-group multi-center trial [O] . Hye Lin Woo, Hae Ri Ji, Siin Kim, 2020

机译：草药（Dangguijagyag-san）对原发性痛经的疗效和安全性：一项随机双盲安慰剂对照平行组多中心试验的研究方案
7. Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study [O] . Yutaka Osuga, Haruka Fujimoto-Okabe, Atsushi Hagino 2017

机译：评估腺炎患者疼痛症状治疗患者痛苦症状的疗效和安全性：随机，双盲，多中心，安慰剂对照研究

A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea

摘要

著录项

相似文献

相关主题

期刊订阅